Getting latest data loading
X

Request a Call to Trade

In addition to the daily Research emails, I would also like to receive the Accendo Markets Weekly Newsletter and occasional Market Report emails highlighting various trading opportunities.
When you enter your telephone number, we may call or message you occasionally with trading opportunities. You can opt out at any time

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Vectura

Does this present a Takeover opportunity for you?

Will anything come of this speculation? Could Vectura shares benefit?

  • N+1 Singer says patent-infringement legal case (awarded $90m) against GSK could revive takeover interest
  • Speculation last year that Vectura it could be a target for Glaxo and Novartis
  • Shares jumped 12.5% yesterday on the above news
  • Shares now 79.3p  (at time of writing)
  • Will this fresh speculation prove much ado about nothing, or could a deal emerge?
  • If speculation intensifies could it drive Vectura shares higher?
  • Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal

Click to enlarge

Trading Vectura – An Example

Let’s say you think that Vectura  is likely to rise further as a result of a takeover offer, towards Dec 2017 highs of 127p. You decide to buy exposure to £10,000 worth of Vectura using a CFD, at the current price of 79.3p. To do this, you need £2,000.

For the purpose of this example, let’s assume the Vectura share price rises by 30%. Your profit would be £3000, from your initial investment of £2,000.

Conversely, let’s assume you open the above position, and place a stop-loss at 5% from the current price. Sentiment towards the deal sours and Vectura and hit your stop-loss. Your loss would be £500.

This is provided for information purposes only. It should not be taken as a recommendation.

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.